STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells için istatistikler

Toplam ziyaret

views
STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells 0

Aylık toplam ziyaret

views
Ocak 2025 0
Şubat 2025 0
Mart 2025 0
Nisan 2025 0
Mayıs 2025 0
Haziran 2025 0
Temmuz 2025 0